Cancer Systems Biology Consortium (CSBC)

Size: px
Start display at page:

Download "Cancer Systems Biology Consortium (CSBC)"

Transcription

1 Cancer Systems Biology Consortium (CSBC) Shannon Hughes, Ph.D. Program Director, Tumor Metastasis Branch Division of Cancer Biology, NCI ITCR PI Teleconference; February 2, 2018

2 Systems Biology at NCI 10 years of the Integrative Cancer Biology Program (ICBP) program evaluation New Initiative - Cancer Systems Biology Consortium (CSBC) Approved March 2015 Three funding announcements issued: Research Centers (), Research Projects (), and Coordinating Center (U24) NCI Program Staff: Erin Wetzel, Dave Miller, Nas Zahir, Shannon Hughes, Jerry Li, Jennifer Couch, Dan Gallahan, Dinah Singer 2

3 Structure of the Cancer Systems Biology Consortium Initiative Coordinating Center U24 Research Center Research Project CSBC Steering Committee Collaborative Projects Working Groups Annual Meetings Outreach (Summer Program) CSBC s: PAR (next receipt date June 22, 2018) CSBC s: RFA-CA (closed) CSBC U24: RFA-CA (closed) 3

4 Current CSBC Portfolio 9 CSBC Research Centers (as of 5/1/17) 1 U24 CSBC/PS-ON Coordinating Center 14 Research Projects 8 Active Collaborative Research in Integrative Cancer Biology (PAR ) 6 CSBC Research Projects (PAR ) Also 5 Active Bridging the Gap Between Cancer Mechanism and Population Science Information on currently funded projects can be found at *** 4

5 Current CSBC / Award Portfolio (23 awards) Categories: Research Theme (2 Major/Minor) Experimental Approaches (2) Computational Approaches (2) For example: Research Theme 1. Tumor Heterogeneity 2. Metastasis 3. Cancer Therapeutics 4. Microenvironment 5. Tumor Immunology 6. Dormancy Research Theme Each Project/Center represented by 6 element vector Ex. MSKCC [ ] Experimental Approach Computational Approach Pairwise Hamming Distance calculated between grants 5

6 Current CSBC / Award Portfolio Edges are weights calculated from Hamming Distance Thicker/Darker line = high similarity Grouped by Research Theme Tumor Heterogeneity Metastasis Cancer Therapeutics Tumor Immune/Stroma Dormancy 6

7 Current CSBC / Award Portfolio Edges are weights calculated from Hamming Distance Thicker line = high similarity Grouped by Research Theme Colored by Experimental Method Genomics/Transcriptomics Proteomics/PPI Imaging Epigenetics Single-Cell Analysis Metabolomics 7

8 Current CSBC / Award Portfolio Edges are weights calculated from Hamming Distance Thicker line = high similarity Grouped by Research Theme Colored by Computational Approach ML/DL Approaches Network Inference/Statistical Ecological/Evolutionary Mechanistic (ODE, etc) 8

9 Example: Combating subclonal evolution of resistant cancer phenotypes Track tumor evolution to determine appropriate treatment options Modified from Brady et al. Nature Comm, Nov Andrea Bild City of Hope CSBC 9

10 Example: Combating subclonal evolution of resistant cancer phenotypes 1) Combination of bulk WGS, WES and targeted single-cell DNA Seq to determine what mutations (subclones) are present in the tumor Dot = mutation Collection of dots = subclone 2) Over time, use single-cell RNASeq to determine which pathways are active in particular clones Modified from Brady et al. Nature Comm, Nov Andrea Bild City of Hope CSBC 10

11 PanCK CD3 CD4 CD8 FoxP3 Non-small cell lung cancer (NSCLC) Slide courtesy of Vivek Mittal Weill Cornell, CSBC

12 Identify key components Stromal cells (Paracrine) or Tumor cells (Autocrine) Differentially upregulated Ligands Expressed Receptors Tumor cells Expressed Transcription Factors/Differentially Expressed Target genes CCCExplorer Algorithm for Crosstalk Signaling Discovery paracrine Ligand-Receptor interactions Downstream signaling pathways G(V,E): signaling pathway V L : up-regulated ligand list V R : expressed receptor list V TF : activated TF list V T :up-regulated target gene list Distance Matrix Combine activated signaling branches autocrine Identify activated signaling pathways as a directed graph V L V R V i Distance 0 Distance 1 Distance 2 V j V TF V T Activated signaling branches (p<0.05) wwww.synapse.org/ CSBCPSON Slide modified from Stephen Wong Methodist Hospital CSBC

13 Ash Alizadeh Stanford CSBC 13

14 Using systems biology to probe tumor-immune interactions and mechanisms of immunotherapy 14

15 Knowledge Portal: gateway to CSBC/PS-ON activities Knowledge Portal Website

16 Building the CSBC/PS-ON Knowledge Portal Exposes and provides access to research activities and resources across Centers and Projects Serves as central gateway for scientific community to discover and utilize consortium material Community CSBC/PS-ON Knowledge Portal R O U24 C Slide care of Justin Guinney, Sage Bionetworks: CSBC/PS-ON Coordinating Center

17 CSBC/PS-ON Summer Undergraduate Research Program Applications are due February 16,

18 November 7-10, 2018 Woods Hole, MA Organized by AECCSB & NCI Scientific Co-chairs: Sylvia Plevritis, Stanford University Sandy Anderson, Moffitt Cancer Center Doug Lauffenburger, MIT See speaker line-up: Travel support will be available for select abstracts. for updates 18

19 Association of Early Career Cancer Systems Biologists (AECCSB) Purpose: Build a cancer systems biology community starting from scientists trained as part of the Integrative Cancer Biology Program. Help ESIs grow a network of like-minded scientists and promote advances by young investigators in the field (aameyer@ucla.edu) (stephen.piccolo.byu@gmail.com)

20 @NCISysBio

Systems Biology and Mathematical Oncology at the National Cancer Institute

Systems Biology and Mathematical Oncology at the National Cancer Institute Systems Biology and Mathematical Oncology at the National Cancer Institute Shannon Hughes, Ph.D. Division of Cancer Biology 240-276-6180 shannon.hughes@nih.gov April 28, 2017 The National Institutes of

More information

Grand Challenge and other funding opportunities at Cancer Research UK. Jamie Meredith, 9 th Dec 15

Grand Challenge and other funding opportunities at Cancer Research UK. Jamie Meredith, 9 th Dec 15 Grand Challenge and other funding opportunities at Cancer Research UK Jamie Meredith, 9 th Dec 15 Multidisciplinary research at CRUK OVERVIEW About CRUK CRUKs research strategy A focus on multidisciplinary

More information

NCI Cancer Moonshot. Christine Siemon National Cancer Institute, NIH. November 30, 2017

NCI Cancer Moonshot. Christine Siemon National Cancer Institute, NIH. November 30, 2017 NCI Cancer Moonshot Christine Siemon National Cancer Institute, NIH November 30, 2017 Presidential Memo 2016 Overall Goals of the Cancer Moonshot Accelerate progress in cancer, including prevention & screening

More information

NCCIH s New Approach to Funding Clinical Trials Informational Webinar. April 18, 2017

NCCIH s New Approach to Funding Clinical Trials Informational Webinar. April 18, 2017 NCCIH s New Approach to Funding Clinical Trials Informational Webinar April 18, 2017 Introductions Wendy Weber, N.D., Ph.D., M.P.H., Branch Chief, Clinical Research in Complementary and Integrative Health

More information

How Systems Biology Can Advance Immune Oncology. Birgit Schoeberl, PhD NEDMG Summer Symposium May 31st

How Systems Biology Can Advance Immune Oncology. Birgit Schoeberl, PhD NEDMG Summer Symposium May 31st How Systems Biology Can Advance Immune Oncology Birgit Schoeberl, PhD NEDMG Summer Symposium May 31st Immuno-Oncology is One of the Most Promising Avenues in the Battle Against Cancer Conventional Therapy

More information

CANCER RESEARCH UK SPONSORSHIP OPPORTUNITIES

CANCER RESEARCH UK SPONSORSHIP OPPORTUNITIES CANCER RESEARCH UK SPONSORSHIP OPPORTUNITIES Cancers of Unmet Need: Our Ambition Over the last 40 years, improvements in prevention, detection and treatment have revolutionised cancer medicine and survival

More information

Spontaneous canine malignancies: Models for precision cancer medicine

Spontaneous canine malignancies: Models for precision cancer medicine National Cancer Institute Spontaneous canine malignancies: Models for precision cancer medicine Amy K. LeBlanc, DVM DACVIM (Oncology) Director, NCI Comparative Oncology Program NIH/NCI Center for Cancer

More information

Sheila Prindiville, MD, MPH Director Coordinating Center for Clinical Trials National Cancer Institute

Sheila Prindiville, MD, MPH Director Coordinating Center for Clinical Trials National Cancer Institute Sheila Prindiville, MD, MPH Director Coordinating Center for Clinical Trials National Cancer Institute NCI and VA Interagency Group to Accelerate Trials Enrollment (NAVIGATE) Sheila A. Prindiville, M.D.,

More information

Confronting the Complexity of Cancer

Confronting the Complexity of Cancer AACR-NCI Conference on Systems Biology February 27-March 2, 2011 Hyatt Regency La Jolla, San Diego, CA Sunday, February 27 6:00 p.m. - 7:00 p.m. Keynote Session Use of bionetworks to build better maps

More information

SWOG Plenary I Translational Medicine Science as the Foundation for Rapid and Meaningful Advances in Oncology

SWOG Plenary I Translational Medicine Science as the Foundation for Rapid and Meaningful Advances in Oncology SWOG Plenary I Translational Medicine Science as the Foundation for Rapid and Meaningful Advances in Oncology Lee M. Ellis, MD SWOG Vice Chair, Translational Medicine Departments of Surgical Oncology and

More information

Update on the NCI Cancer Centers Program Henry P. Ciolino, Ph.D. Director, Office of Cancer Centers

Update on the NCI Cancer Centers Program Henry P. Ciolino, Ph.D. Director, Office of Cancer Centers Update on the NCI Cancer Centers Program Henry P. Ciolino, Ph.D. Director, Office of Cancer Centers April 30, 2017 History of the CCSG Funding Opportunity Announcement What hasn t changed What has changed

More information

Spontaneous canine malignancies: Models for precision cancer medicine

Spontaneous canine malignancies: Models for precision cancer medicine National Cancer Institute Spontaneous canine malignancies: Models for precision cancer medicine Amy K. LeBlanc, DVM DACVIM (Oncology) Director, NCI Comparative Oncology Program NIH/NCI Center for Cancer

More information

Predicting outcome from cancer data

Predicting outcome from cancer data Predicting outcome from cancer data Jeffrey Chuang The Jackson Laboratory for Genomic Medicine Drowning in data, thirsting for knowledge 2 Clinical outcome across cancer types TCGA Cancer types 5-year

More information

Clinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer

Clinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer Clinical Trials: Advanced or Metastatic Bladder Cancer Wednesday June 22 nd, 2016 Part III: Question and Answer Questions Answered by Andrea Apolo, MD is a Lasker Clinical Research Scholar and tenure-track

More information

Impressions of a New NCI Director: Big Data

Impressions of a New NCI Director: Big Data Impressions of a New NCI Director: Big Data Norman E. Sharpless, M.D. Cancer Informatics for Cancer Centers April 3, 2018 www.cancer.gov www.cancer.gov/espanol October 17, 2018 NCI: Leading the National

More information

VISION» FOCUS DISCOVERY» CREATION

VISION» FOCUS DISCOVERY» CREATION The Women s Health Research Institute at Northwestern University is turning possibility into reality. The possibility that we can improve women s health by requiring that all research studies put greater

More information

US Opportunities at the Intersection of Physical and Life Sciences

US Opportunities at the Intersection of Physical and Life Sciences US Opportunities at the Intersection of Physical and Life Sciences Jonathan Franca Koh Program Manager Physical Sciences Oncology Centers (PS OC) Program, Office of Physical Sciences Oncology (OPSO), CSSI,

More information

NCI, Prevention, and Screening

NCI, Prevention, and Screening NCI, Prevention, and Screening Doug Lowy, M.D. Acting Director, National Cancer Institute, NIH AACR Cancer Prevention Summit February 3, 2016 Outline of Presentation Cancer mortality trends NCI budget

More information

BIMM134 The Biology of Cancer Winter 2019

BIMM134 The Biology of Cancer Winter 2019 BIMM134 The Biology of Cancer Winter 2019 Lectures: Center Hall Room 119 Tuesdays/Thursdays; 3:30 4:50 PM January 9 March 15 Discussion Sections: Wednesday 12-1 CSB 001 Friday 12-1 CSB 001 Instructor:

More information

Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They?

Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They? Identifying Novel Targets for Non-Small Cell Lung Cancer Just How Novel Are They? Dubovenko Alexey Discovery Product Manager Sonia Novikova Solution Scientist September 2018 2 Non-Small Cell Lung Cancer

More information

2017 CURE - Sleep and Epilepsy Award Request for Applications (RFA) with LOI & Full Proposal Guidelines

2017 CURE - Sleep and Epilepsy Award Request for Applications (RFA) with LOI & Full Proposal Guidelines 2017 CURE - Sleep and Epilepsy Award Request for Applications (RFA) with LOI & Full Proposal Guidelines About CURE CURE s mission is to cure epilepsy, transforming and saving millions of lives. We identify

More information

Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships

Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships The National Academies of SCIENCES ENGINEERING MEDICINE Advancing Therapeutic Development for Pain and Opioid Use Disorder through Public-Private Partnerships Leadership The NIH Pain Consortium Mission

More information

PROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund

PROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund PROGRESS UPDATE Evan T. Mandeville DIPG Research Fund December 2018 EXECUTIVE SUMMARY As a top-ranked pediatric cancer center, Dana-Farber Cancer Institute combines first-rate patient care with groundbreaking

More information

The Cancer Moonshot ECCO2018 September 7, 2018

The Cancer Moonshot ECCO2018 September 7, 2018 The Cancer Moonshot ECCO2018 September 7, 2018 Dinah S. Singer, Ph.D. Deputy Director National Cancer Institute, NIH www.cancer.gov/moonshot Goals of the Cancer Moonshot Accelerate progress in cancer,

More information

CAR T Cell Therapies Workshop

CAR T Cell Therapies Workshop CAR T Cell Therapies Workshop May 15, 2018 Hilton Chicago Continental B Chicago Table of Contents CAR T Cell Therapies Workshop Supporters... p 2 Committee Listing... p 3 Faculty Listing... p 3 Faculty

More information

Immediate Past President National Medical Association

Immediate Past President National Medical Association Improved Survival but Continued Disparities in Cancer: The 1971 National Cancer Act through Moonshot 2017 Edith Peterson Mitchell, MD, FACP, FCPP Clinical Professor of Medicine and Medical Oncology Department

More information

When fighting lung cancer, every cancer is personal 18 November 2014, by Sylvia Wrobel

When fighting lung cancer, every cancer is personal 18 November 2014, by Sylvia Wrobel When fighting lung cancer, every cancer is personal 18 November 2014, by Sylvia Wrobel lung cancer clinical trials underway at Winship, thanks to Winship's status as Georgia's only National Cancer Institute-designated

More information

8/17/2011. FY 2010 President s Budget Request Total NIH Budget Authority $31.0 Billion

8/17/2011. FY 2010 President s Budget Request Total NIH Budget Authority $31.0 Billion NIH OD NCI NEI NHLBI NHGRI NIA NIAAA NIAID NIAMS NIBIB NICHD NIDCD NIDCR NIDDK NIDA NIEHS NIGMS NIMH NINDS NINR NLM CIT CSR FIC NCCAM NCMHD NCRR FY 2010 President s Budget Request Total NIH Budget Authority

More information

4th Central Eastern European Symposium on Free Nucleic Acids in Non-Invasive Prenatal Diagnosis Split, May Second Announcement

4th Central Eastern European Symposium on Free Nucleic Acids in Non-Invasive Prenatal Diagnosis Split, May Second Announcement Josip Juraj Strossmayer University of Osijek FACULTY OF MEDICINE OSIJEK 4th Central Eastern European Symposium on Free Nucleic Acids in Non-Invasive Prenatal Diagnosis Split, 25-26 May 2016 Second Announcement

More information

Epigenetic programming in chronic lymphocytic leukemia

Epigenetic programming in chronic lymphocytic leukemia Epigenetic programming in chronic lymphocytic leukemia Christopher Oakes 10 th Canadian CLL Research Meeting September 18-19 th, 2014 Epigenetics and DNA methylation programming in normal and tumor cells:

More information

Gene x Environment x Development Interactions (GEDI) NIDA Strategic Planning Workgroup. April 17, Organizational Meeting

Gene x Environment x Development Interactions (GEDI) NIDA Strategic Planning Workgroup. April 17, Organizational Meeting Gene x Environment x Development Interactions (GEDI) NIDA Strategic Planning Workgroup April 17, 2015 Organizational Meeting Co-Chairs: Naimah Weinberg, M.D. (NIDA) Jonathan Pollock, Ph.D. (NIDA) Slide

More information

New NCCIH Funding Opportunities for Mind and Body Clinical Trials. April 24, 2017

New NCCIH Funding Opportunities for Mind and Body Clinical Trials. April 24, 2017 New NCCIH Funding Opportunities for Mind and Body Clinical Trials April 24, 2017 Introductions Wendy Weber, N.D., Ph.D., M.P.H. Branch Chief, Clinical Research in Complementary and Integrative Health Branch,

More information

BRP update from the NCI Acting Director

BRP update from the NCI Acting Director BRP update from the NCI Acting Director Douglas R. Lowy Acting Director, National Cancer Institute National Institutes of Health BRP Virtual Meeting May 9, 2017 NCI APPROPRIATIONS 2013-2017 (in billions)

More information

ORIEN NOVA TEAM SCIENCE AWARD

ORIEN NOVA TEAM SCIENCE AWARD ORIEN NOVA TEAM SCIENCE AWARD CALL FOR LETTERS OF INTENT BACKGROUND: The Oncology Research Information Exchange Network (ORIEN) is a unique alliance to integrate data sharing and collaborative learning

More information

Certificate of Advanced Studies in Personalized Molecular Oncology

Certificate of Advanced Studies in Personalized Molecular Oncology Certificate of Advanced Studies in Personalized Molecular Oncology Certificate of Advanced Studies (CAS) in Personalized Molecular Oncology Overview Cutting-edge technologies, like next-generation-sequencing

More information

John Templeton Foundation

John Templeton Foundation John Templeton Foundation In keeping with Sir John Templeton's intent, his Foundation serves as a philanthropic catalyst for research and discoveries relating to what scientists and philosophers call the

More information

PROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund

PROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund PROGRESS UPDATE Evan T. Mandeville DIPG Research Fund October 2017 EXECUTIVE SUMMARY Investigators at Dana-Farber Cancer Institute are global leaders in pediatric brain tumor research and patient care,

More information

CONTRACTING ORGANIZATION: Joan & Sanford I. Weill Medical College of Cornell University New York, NY 10065

CONTRACTING ORGANIZATION: Joan & Sanford I. Weill Medical College of Cornell University New York, NY 10065 AWARD NUMBER: W81XWH-14-1-0263 TITLE: Early Detection of NSCLC Using Stromal Markers in Peripheral Blood PRINCIPAL INVESTIGATOR: Dingcheng Gao CONTRACTING ORGANIZATION: Joan & Sanford I. Weill Medical

More information

Affiliate Highlight: Fellow Gains New Perspective on the Impact of Breast Cancer Research

Affiliate Highlight: Fellow Gains New Perspective on the Impact of Breast Cancer Research Page 1 of 5 Share Past Issues Komen Research Updates 2013 ASCO Annual Meeting, Exciting Research Grantee Announcements, and more! Table of Contents: Affiliate Highlight: Fellow Gains New Perspective on

More information

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC) Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts 08-24-2018 Table of Contents (TOC) Notices Notice of Webinar for PAR 18 307 "Developing Interventions for Health Enhancing

More information

Neutral evolution in colorectal cancer, how can we distinguish functional from non-functional variation?

Neutral evolution in colorectal cancer, how can we distinguish functional from non-functional variation? in partnership with Neutral evolution in colorectal cancer, how can we distinguish functional from non-functional variation? Andrea Sottoriva Group Leader, Evolutionary Genomics and Modelling Group Centre

More information

Conference Theme. Pre-Conference Events

Conference Theme. Pre-Conference Events Conference Theme Pediatric cancers are the leading cause of disease-related death in children however, childhood cancers possess a distinct etiology defined as a rare disease when contrasted with the adult

More information

NIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH

NIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH NIH HEAL Initiative: Program Update and Funding Opportunities for Pain Research Available through NIH AAMC Webinar November 8, 2018 Walter J. Koroshetz, MD Director, National Institute of Neurological

More information

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC) Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts 12-15-2017 Table of Contents (TOC) All NIH Funding Opportunities and Notices Notices Additional Short-Term Administrative

More information

Vaccines and Immunization research & development

Vaccines and Immunization research & development 32 nd International conference on Vaccines and Immunization research & development 0 http://vaccines.global-summit.com/america/ Invitation Dear Attendees, We are glad to announce the 32 nd International

More information

PROGRESS UPDATE. Lauren s First and Goal

PROGRESS UPDATE. Lauren s First and Goal PROGRESS UPDATE Lauren s First and Goal August 2015 EXECUTIVE SUMMARY The Pediatric Low-Grade Astrocytoma (PLGA) Program at Dana-Farber Cancer Institute is committed to improving outcomes for young patients

More information

NIDDK: Priorities and Perspectives. NIDDK: Support of Fatty Liver Disease Research. National Institutes of Health $30,142,653,000

NIDDK: Priorities and Perspectives. NIDDK: Support of Fatty Liver Disease Research. National Institutes of Health $30,142,653,000 NIDDK: Priorities and Perspectives Edward Doo Program Director Liver Diseases Research Branch, NIDDK National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health STOPNASH

More information

PROGRESS UPDATE. The Prayers From Maria Foundation

PROGRESS UPDATE. The Prayers From Maria Foundation PROGRESS UPDATE The Prayers From Maria Foundation August 2016 EXECUTIVE SUMMARY Dana-Farber Cancer Institute is a global leader in discovery science and patient care for pediatric brain tumors, including

More information

Newsletter. August 7, Visit

Newsletter. August 7, Visit Share: Tweet Newsletter August 7, 2013 Jump to a Topic: Upcoming Events Funding Opportunities Conferences and Meetings Announcements Check out our new website! We are excited to announce the launching

More information

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data Breast cancer Inferring Transcriptional Module from Breast Cancer Profile Data Breast Cancer and Targeted Therapy Microarray Profile Data Inferring Transcriptional Module Methods CSC 177 Data Warehousing

More information

DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014

DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014 DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014 Karen Arts, Director Canadian Cancer Clinical Trial Network (3CTN) Chair of the Board of N2 Administrative Office: Lawson

More information

On Human Natures: Psychological Science in the Service of Theology Application Information Packet

On Human Natures: Psychological Science in the Service of Theology Application Information Packet On Human Natures: Psychological Science in the Service of Theology Application Information Packet A program to support science-engaged theology, training theologians in psychological science, to make new

More information

Request for Applications Basic, Clinical and Population Science Pilot Awards

Request for Applications Basic, Clinical and Population Science Pilot Awards Request for Applications Basic, Clinical and Population Science Pilot Awards Spring, 2013 SUMMARY The University of Wisconsin Carbone Cancer Center (UWCCC) is an NCI-designated Comprehensive Cancer Center

More information

Population Science and Community Engagement

Population Science and Community Engagement Population Science and Community Engagement Elizabeth Shenkman, PhD Professor and Chair Health Outcomes & Policy Co-Director, OneFlorida Clinical Research Consortium 1 Key Initiatives Cancer Prevention

More information

2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme

2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme 2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme Thursday 1 st December 2016 09.15am 10.00am Registration and Refreshments 10.15am 10.30am Welcome 10.30am 11.15am Opening

More information

Cancer Moonshot Blue Ribbon Panel Report.

Cancer Moonshot Blue Ribbon Panel Report. Cancer Moonshot Blue Ribbon Panel Report www.cancer.gov/brp Goals of the Cancer Moonshot Accelerate progress in cancer, including prevention & screening From cutting edge basic research to wider uptake

More information

Melanoma Research Foundation Request for Proposals (RFP) 2017

Melanoma Research Foundation Request for Proposals (RFP) 2017 Melanoma Research Foundation Request for Proposals (RFP) 2017 RESEARCH OVERVIEW: The Melanoma Research Foundation (MRF) is committed to advancing research across the spectrum of melanoma from prevention

More information

CLL Sample! Clinical Trials! Accrual, tracking,! correlative studies! Immunophenotyping! Surface & intracellular! ZAP-70/CD38! prognosis!

CLL Sample! Clinical Trials! Accrual, tracking,! correlative studies! Immunophenotyping! Surface & intracellular! ZAP-70/CD38! prognosis! ZAP-70/CD38! prognosis! IGHV! Mutational status! prognosis! Cytogenetics! FISH! karyotype! Cellular Kinetics! B-cell turnover rates! CD38/Ki67/CXCR4! Buccal swabbs! Germline DNA! Genetics studies! Immunophenotyping!

More information

Improving the Mental Health and Wellbeing of Adolescents and Young Adults

Improving the Mental Health and Wellbeing of Adolescents and Young Adults Spring 2017 Update Improving the Mental Health and Wellbeing of Adolescents and Young Adults In this update à Our Center is expanding! Meet our new team members. à Bringing the headspace model to the Bay

More information

Nature Immunology: doi: /ni Supplementary Figure 1. RNA-Seq analysis of CD8 + TILs and N-TILs.

Nature Immunology: doi: /ni Supplementary Figure 1. RNA-Seq analysis of CD8 + TILs and N-TILs. Supplementary Figure 1 RNA-Seq analysis of CD8 + TILs and N-TILs. (a) Schematic representation of the tumor and cell types used for the study. HNSCC, head and neck squamous cell cancer; NSCLC, non-small

More information

NIH-NCI Newsletter. National Cancer Institute Population-based Research to Optimize the Screening Process (PROSPR) (UM1) RFA-CA

NIH-NCI Newsletter. National Cancer Institute Population-based Research to Optimize the Screening Process (PROSPR) (UM1) RFA-CA NIH-NCI Newsletter Population-based Research to Optimize the Screening Process (PROSPR) (UM1) RFA-CA-16-016 Application Due Date: February 9, 2017 "http://grants.nih.gov/grants/guide/rfa-files/rfa-ca-16-016.html"

More information

Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications

Advances in Breast Cancer Research: Genetics, Biology, and Clinical Applications An AACR Special Conference on October 12-15, 2011 The Fairmont San Francisco San Francisco, CA Wednesday, October 12 7:00 p.m.-8:00 p.m. Opening Keynote Address Chairperson: Jeffrey M. Rosen, Baylor College

More information

Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor suppressor genes

Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor suppressor genes Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor suppressor genes Kaifu Chen 1,2,3,4,5,10, Zhong Chen 6,10, Dayong Wu 6, Lili Zhang 7, Xueqiu Lin 1,2,8,

More information

Request for Applications Post-Traumatic Stress Disorder GWAS

Request for Applications Post-Traumatic Stress Disorder GWAS Request for Applications Post-Traumatic Stress Disorder GWAS PROGRAM OVERVIEW Cohen Veterans Bioscience & The Stanley Center for Psychiatric Research at the Broad Institute Collaboration are supporting

More information

Nobel Laureate Harold Varmus Joins Weill Cornell Medical College to Advance Cancer Research

Nobel Laureate Harold Varmus Joins Weill Cornell Medical College to Advance Cancer Research Contact: Weill Cornell Medical College New York Genome Center Sarah Smith Sara Ghazaii sas2072@med.cornell.edu sghazaii@nygenome.org 646-317-7401 646-977-7070 Nobel Laureate Harold Varmus Joins Weill Cornell

More information

Emerging Tissue and Serum Markers

Emerging Tissue and Serum Markers Emerging Tissue and Serum Markers for Immune Checkpoint Inhibitors Kyong Hwa Park MD, PhD Medical Oncology Korea University College of Medicine Contents Immune checkpoint inhibitors in clinical practice

More information

Theme: Prospects and Development of Prophylactic & Therapeutic Vaccines.

Theme: Prospects and Development of Prophylactic & Therapeutic Vaccines. conferenceseries.com Tentative Program 32 nd International conference on Vaccines and Immunization R&D, B2B November 9-10, 2018 Atlanta, Georgia, USA Theme: Prospects and Development of Prophylactic &

More information

2015 AP Biology Unit #4 Quiz 1 Cell Communication, Cancer and The Cell Cycle Week of November

2015 AP Biology Unit #4 Quiz 1 Cell Communication, Cancer and The Cell Cycle Week of November Name: Class: Date: 2015 AP Biology Unit #4 Quiz 1 Cell Communication, Cancer and The Cell Cycle Week of 16-20 November Multiple Choice Identify the choice that best completes the statement or answers the

More information

Should novel molecular therapies replace old knowledge of clinical tumor biology?

Should novel molecular therapies replace old knowledge of clinical tumor biology? Should novel molecular therapies replace old knowledge of clinical tumor biology? Danai Daliani, M.D. Director, 1 st Oncology Clinic Euroclinic of Athens Cancer Treatments Localized disease Surgery XRT

More information

New technologies for studying human immunity. Lisa Wagar Postdoctoral fellow, Mark Davis lab Stanford University School of Medicine

New technologies for studying human immunity. Lisa Wagar Postdoctoral fellow, Mark Davis lab Stanford University School of Medicine New technologies for studying human immunity Lisa Wagar Postdoctoral fellow, Mark Davis lab Stanford University School of Medicine New strategies: Human immunology is ideal for a systems approach We have

More information

Future Faces of Physics Award Proposal

Future Faces of Physics Award Proposal Future Faces of Physics Award Proposal Project Proposal Title Name of School The Signs of Physics University of Central Arkansas SPS Chapter Number 1059 Total Amount Requested $300.00 Abstract The Society

More information

Progress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader:

Progress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader: SU2C -Ovarian Cancer Research Fund Alliance-National Ovarian Cancer Coalition Dream Team Translational Research Grant: DNA Repair Therapies for Ovarian Cancer AND SU2C Catalyst Merck-Supported Supplemental

More information

Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment

Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment Immune Checkpoint Inhibitors: The New Breakout Stars in Cancer Treatment 1 Introductions Peter Langecker, MD, PhD Executive Medical Director, Global Oncology Clinipace Worldwide Mark Shapiro Vice President

More information

The Alzheimer s Disease Centers Program: updates

The Alzheimer s Disease Centers Program: updates The Alzheimer s Disease Centers Program: updates Nina Silverberg, Ph.D Director, Alzheimer s Disease Centers Program, NIA Presented at Directors Meeting, October 20, 2018, Atlanta, GA Polleverywhere Feedback

More information

Melanoma Research Foundation Request for Proposals (RFP) 2019

Melanoma Research Foundation Request for Proposals (RFP) 2019 Melanoma Research Foundation Request for Proposals (RFP) 2019 RESEARCH OVERVIEW: The Melanoma Research Foundation (MRF) is committed to advancing research across the spectrum of melanoma from prevention

More information

Cancer Biology Annual Retreat

Cancer Biology Annual Retreat Cancer Biology Annual Retreat Kiawah Island, South Carolina October 25-27, 2015 Agenda Sunday, October 25 9:00 am 12:00 pm Executive Committee/Board Meeting 2:00 pm 7:00 pm Welcome Lounge & Registration

More information

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC)

Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts Table of Contents (TOC) Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts 01-12-2018 Table of Contents (TOC) All NIH Funding Opportunities and Notices Notices NIH Operates Under a Continuing Resolution

More information

COST ACTION CA IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN)

COST ACTION CA IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN) COST ACTION CA17118 - IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN) Working group 1 participant duties - Align with the scientific

More information

Kansas Respiratory Care Society January 8, 2016 Salina Regional Health Center Salina, KS

Kansas Respiratory Care Society January 8, 2016 Salina Regional Health Center Salina, KS Kansas Respiratory Care Society January 8, 2016 Salina Regional Health Center Salina, KS Attending Terri Lesser, Monica Baden, Don Richards, Jessica Callaway, Charity Clark, Glenn Tammen, Jerry Houchin,

More information

Agenda for the Metastatic Breast Cancer (MBC) Engagement Conference at Moffitt Cancer Center. June 22-23, 2018

Agenda for the Metastatic Breast Cancer (MBC) Engagement Conference at Moffitt Cancer Center. June 22-23, 2018 Agenda for the Metastatic Breast Cancer (MBC) Engagement Conference at Moffitt Cancer Center June 22-23, 2018 Note: ** Indicates the activity has been approved for AMA PRA Category 1 Credit jointly provided

More information

The 100,000 Genomes Project

The 100,000 Genomes Project The 100,000 Genomes Project Dr Matina Prapa, Scientific co ordinator Genomics England Clinical Interpretation Partnership William Harvey Research Institute Queen Mary University of London Genomics England

More information

Accelerating Translation at Dana-Farber Cancer Institute*

Accelerating Translation at Dana-Farber Cancer Institute* Accelerating Translation at Dana-Farber Cancer Institute* *and our partner institutions February 12, 2013 Edward J Benz JR, MD Dana Farber Cancer Institute 1 2 Academic Structure All Dana-Farber faculty

More information

Dahshu Virtual Journal Club

Dahshu Virtual Journal Club Dahshu Virtual Journal Club DahShu is a nonprofit organization with the mission of promoting research and education in data science For more information, visit: http://www.dahshu.org/ Questions? Contact

More information

Parkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist and Movement Disorders Specialist as Chief Medical Officer

Parkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist and Movement Disorders Specialist as Chief Medical Officer Press Release For Immediate Release October 30, 2017 Contact: Chris Di Salvo Mobile: (408) 506-0455 E-mail: profeff@aol.com Parkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist

More information

Cell Communication. Chapter 11. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for

Cell Communication. Chapter 11. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for Chapter 11 Cell Communication PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp

More information

COST ACTION CA IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN)

COST ACTION CA IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN) COST ACTION CA17118 - IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN) Working group 1 management committee duties - Contribute

More information

BRANCHED-CHAIN AMINO ACIDS FOUND TO REGULATE THE DEVELOPMENT AND PROGRESSION OF CANCER

BRANCHED-CHAIN AMINO ACIDS FOUND TO REGULATE THE DEVELOPMENT AND PROGRESSION OF CANCER SCIENTIFIC ADVISORY BRANCHED-CHAIN AMINO ACIDS FOUND TO REGULATE THE DEVELOPMENT AND PROGRESSION OF CANCER Researchers from A*STAR s SBIC have discovered how changes in BCAA metabolism influence the development

More information

The Breast Cancer Research Foundation

The Breast Cancer Research Foundation Advances in Experimental Medicine and Biology The Breast Cancer Research Foundation Larry Norton, MD Medical Director, Evelyn H. Lauder Breast Center Memorial Sloan Kettering Cancer Center Professor of

More information

Integrating Geriatrics into the Specialties of Internal Medicine. Workshop on Wound Repair and Healing in Older Adults February 20-21, 2014

Integrating Geriatrics into the Specialties of Internal Medicine. Workshop on Wound Repair and Healing in Older Adults February 20-21, 2014 Integrating Geriatrics into the Specialties of Internal Medicine Workshop on Wound Repair and Healing in Older Adults February 20-21, 2014 Funded by grants by The John A Hartford Foundation and NIA to

More information

Melanoma Research Alliance-Pfizer Academic-Industry Partnership Awards

Melanoma Research Alliance-Pfizer Academic-Industry Partnership Awards Melanoma Research Alliance-Pfizer Academic-Industry Partnership Awards Wendy K.D. Selig, President & CEO, MRA Julia Perkins, M.D. Medical Director, Oncology, Pfizer Melanoma Research Alliance Mission:

More information

Bases for Immunotherapy in Multiple Myeloma

Bases for Immunotherapy in Multiple Myeloma Bases for Immunotherapy in Multiple Myeloma Paola Neri, MD, PhD Associate Professor of Medicine University of Calgary, Arnie Charbonneau Cancer Institute Disclosures Paola Neri MD, PhD Grants/research

More information

TREAT-NMD Partner Newsletter No th June 2007 and Club of Interest Newsletter No. 11

TREAT-NMD Partner Newsletter No th June 2007 and Club of Interest Newsletter No. 11 TREAT-NMD Partner Newsletter No. 17 29 th June 2007 and Club of Interest Newsletter No. 11 Welcome to the eleventh newsletter for the TREAT-NMD Club of Interest. This week s edition features a report on

More information

Course Organizers: Neal Copeland, Ph.D., The Houston Methodist Research Institute Nancy Jenkins, Ph.D., The Houston Methodist Research Institute

Course Organizers: Neal Copeland, Ph.D., The Houston Methodist Research Institute Nancy Jenkins, Ph.D., The Houston Methodist Research Institute Saturday, August 20 25 th ANNUAL SHORT COURSE ON EXPERIMENTAL MODELS OF HUMAN CANCER August 20-28, 2016 Course Organizers: Neal Copeland, Ph.D., The Houston Methodist Research Institute Nancy Jenkins,

More information

3D-Tissue Microsystems for Tumor Microenvironments Designs for Basic and Translational Research

3D-Tissue Microsystems for Tumor Microenvironments Designs for Basic and Translational Research 3D-Tissue Microsystems for Tumor Microenvironments Designs for Basic and Translational Research Michael Phelan Biostatistics Shared Resource Chao Family Comprehensive Cancer Center UC, Irvine School of

More information

Hepatitis B Foundation (HBF) Meetings with National Institutes for Health (NIH) On Research Opportunities For Finding A Cure For HBV March 12, 2018

Hepatitis B Foundation (HBF) Meetings with National Institutes for Health (NIH) On Research Opportunities For Finding A Cure For HBV March 12, 2018 Hepatitis B Foundation (HBF) Meetings with National Institutes for Health (NIH) On Research Opportunities For Finding A Cure For HBV March 12, 2018 Carol L. Brosgart, MD Member, Board of Directors, Hepatitis

More information

The Intersection of Nutrition and Genetics. Beverly K. Jordan, MPA Director of Community Outreach

The Intersection of Nutrition and Genetics. Beverly K. Jordan, MPA Director of Community Outreach The Intersection of Nutrition and Genetics Beverly K. Jordan, MPA Director of Community Outreach The Intersection of Nutrition and Genetics Objectives Learn about the work happening at the new UNC-Chapel

More information

NCRI Biomarkers & Imaging CSG Cell-free DNA workshop

NCRI Biomarkers & Imaging CSG Cell-free DNA workshop NCRI Biomarkers & Imaging CSG Cell-free DNA workshop Workshop Report Christie Education Centre, Manchester 30th January 2014 Sponsored by Workshop summary 86 delegates from a variety of specialities attended

More information

Single-Cell Sequencing in Cancer. Peter A. Sims, Columbia University G4500: Cellular & Molecular Biology of Cancer October 22, 2018

Single-Cell Sequencing in Cancer. Peter A. Sims, Columbia University G4500: Cellular & Molecular Biology of Cancer October 22, 2018 Single-Cell Sequencing in Cancer Peter A. Sims, Columbia University G4500: Cellular & Molecular Biology of Cancer October 22, 2018 Lecture will focus on technology for and applications of single-cell RNA-seq

More information